RSA Insurance Group Receives Hold Rating from Canaccord Genuity (RSA)
RSA Insurance Group (LON:RSA)‘s stock had its “hold” rating reiterated by investment analysts at Canaccord Genuity in a note issued to investors on Friday, AR Network reports. They currently have a GBX 120 ($1.94) price objective on the stock. Canaccord Genuity’s target price indicates a potential upside of 0.08% from the stock’s previous close.
Shares of RSA Insurance Group (LON:RSA) traded down 0.50% on Friday, hitting GBX 119.30. The stock had a trading volume of 8,449,109 shares. RSA Insurance Group has a 52 week low of GBX 107.30 and a 52 week high of GBX 137.30. The stock’s 50-day moving average is GBX 121.7 and its 200-day moving average is GBX 118.1. The company’s market cap is £4.355 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at Morgan Stanley raised their price target on shares of RSA Insurance Group (LON:RSA) from GBX 127 ($2.05) to GBX 136 ($2.19) in a research note to investors on Thursday. They now have an “overweight” rating on the stock. Separately, analysts at AlphaValue reiterated an “add” rating on shares of RSA Insurance Group (LON:RSA) in a research note to investors on Tuesday. They now have a GBX 140 ($2.26) price target on the stock. Finally, analysts at Bank of America Corp. reiterated a “neutral” rating on shares of RSA Insurance Group (LON:RSA) in a research note to investors on Monday. They now have a GBX 125 ($2.02) price target on the stock. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of GBX 129.20 ($2.08).
RSA Insurance Group plc is the holding company engaged in personal and commercial general insurance business.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.